Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.740
-0.070 (-3.87%)
At close: Apr 24, 2026, 4:00 PM EDT
1.790
+0.050 (2.87%)
After-hours: Apr 24, 2026, 7:58 PM EDT
Annovis Bio Employees
Annovis Bio had 7 employees as of December 31, 2025. The number of employees decreased by 8 or -53.33% compared to the previous year.
Employees
7
Change (1Y)
-8
Growth (1Y)
-53.33%
Revenue / Employee
n/a
Profits / Employee
-$4,122,028
Market Cap
60.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -8 | -53.33% | 7 | 0 |
| Dec 31, 2024 | 15 | -1 | -6.25% | 8 | 7 |
| Dec 31, 2023 | 16 | 11 | 220.00% | 6 | 10 |
| Dec 31, 2022 | 5 | 2 | 66.67% | 5 | 0 |
| Dec 31, 2021 | 3 | 1 | 50.00% | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 102 |
| OnKure Therapeutics | 45 |
| BeyondSpring | 44 |
| iBio, Inc. | 20 |
| Edesa Biotech | 17 |
| ImageneBio | 15 |
| Cingulate | 14 |
| Actuate Therapeutics | 12 |
ANVS News
- 14 days ago - Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission - GlobeNewsWire
- 15 days ago - Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants - GlobeNewsWire
- 22 days ago - Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections - GlobeNewsWire
- 24 days ago - Annovis Publishes Historical Review of Buntanetap in The Scientist - GlobeNewsWire
- 5 weeks ago - Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study - GlobeNewsWire
- 5 weeks ago - NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial - GlobeNewsWire
- 5 weeks ago - Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference - GlobeNewsWire